Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

TitleMolecular determinants of crosstalk between nuclear receptors and toll-like receptors.
Publication TypeJournal Article
Year of Publication2005
AuthorsOgawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK
JournalCell
Volume122
Issue5
Pagination707-21
Date Published2005 Sep 9
ISSN0092-8674
KeywordsAnimals, DNA-Binding Proteins, Gene Expression Profiling, Interferon Regulatory Factor-3, Interferon Regulatory Factor-7, Lipopolysaccharides, Macrophages, Membrane Glycoproteins, Mice, NF-kappa B, Orphan Nuclear Receptors, PPAR gamma, Receptor Cross-Talk, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear, Receptors, Glucocorticoid, Signal Transduction, Toll-Like Receptor 3, Toll-Like Receptor 4, Toll-Like Receptors, Transcription Factor RelA, Transcription Factors
Abstract

Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal- and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPARgamma and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.

DOI10.1016/j.cell.2005.06.029
PubMed URLhttp://www.ncbi.nlm.nih.gov/pubmed/16143103?dopt=Abstract
PMCPMC1430687
Alternate TitleCell
PubMed ID16143103